Shunqikaiyuhuatan Soup In Treatment Of Reflux Esophagitis With Qi Stagnation And Phlegm Stagnation Syndrome

Objective: To investigate Shunqikaiyuhuatan soup in treatment of reflux esophagitis with qi stagnation and phlegm stagnation syndrome's pesticide effect, safety and clinical application value.Methods: Select Hunan University of Traditional Chinese Medicine, First Affiliated Hospital gastroenterology clinic, inpatient department, endoscopy room, as well as social recruitment line with reflux esophagitis with qi stagnation and phlegm stagnation syndrome Standards of volunteers 60 cases, the treatment group 30 cases and the control group 30 cases, respectively to give Shunqikaiyuhuatan soup and Omeprazole, Domperidone, 8 weeks of treatment, the clinical symptoms and signs of change before and after treatment, and detected the changes of esophageal mucosa under gastroscopy.Results: 1.Treatment group and control group after treatment, the total efficiency of 89.6%, 71.4%, and the difference was statistically significant(P <0.05), Indicate Shunqikaiyuhuatan soup in the treatment of reflux esophagitis with qi stagnation and phlegm stagnation syndrome is better than western medicine group. 2.Treatment and control groups before treatment, symptom score comparison, the difference was not statistically significant(P> 0.05), comparable; After treatment,symptom score, compared with before treatment, the difference was statistically significant(P <0.05), description of treatment in the two groups can to improve reflux esophagitis with qi stagnation and phlegm stagnation patients; while after treatment between the two groups was statistically significant(P <0.05), Shunqikaiyuhuatan soup in the treatment of reflux esophagitis with qi stagnation and phlegm stagnation syndrome is better than western medicine group. 3. Two groups on the symptoms have improved significantly(P <0.05), but the treatment group of throat such as phlegm, poor emotional aggravating, chest discomfort, acid regurgitation, heartburn, dysphagia, melancholy superior to the control group(P <0.05). 4. Comparison of endoscopic score between the treatment group and the control group before treatment, the difference was not statistically significant(P> 0.05), comparable; After treatment, symptom score, compared with before treatment, the difference was statistically significant(P <0.05), two groups of treatment can improve the performance of endoscopic esophageal mucosal RE patients, while after treatment between the two groups was statistically significant(P <0.05), Shunqikaiyuhuatan soup in the treatment of reflux esophagitis with esophageal mucosa under endoscopy in patients is better than western medicine group. 5. The two groups in the course of treatment there were no adverse reactions that Shunqikaiyuhuatan soup open stagnation of Phlegm Decoction in the treatment of reflux esophagitis gas stagnation of phlegm syndrome is safe and effective.Conclusion: Shunqikaiyuhuatan soup in the treatment of reflux esophagitis with qi stagnation and phlegm stagnation syndrome patients total effective rate of 89.6%, Chinese medicine clinical symptoms of patients with reflux esophagitis and qi stagnation and phlegm stagnation syndrome can be obviously improved, to improve the performance of endoscopic esophageal mucosa.